Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
September 2004
2004:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2005 | 2006 | 2007 | 2008
News | News in brief | News Features
News
Bush backs Bement to head science agency
Arden Bement, a metallurgist with a strong track record in industry, government and the academic world, has been nominated by the US president, George W. Bush, to serve as the National Science Foundation's twelfth director.
Nature (23 September 2004)
| Full Text |
US health agency opens landmark clinical centre
Clinical research at the National Institutes of Health (NIH) was due to receive a major boost this week with the official opening of a 242-bed, $540-million centre at the agency's main campus in Bethesda, Maryland.
Nature (23 September 2004)
| Full Text |
Students set up forum to debate hot topics
Graduate students at the University of Washington in Seattle are leading an initiative to encourage dialogue between scientists and the public on hot research issues.
Nature (23 September 2004)
| Full Text |
Security restrictions lead foreign students to snub US universities
The number of foreign graduate students admitted to top US research institutions has declined precipitously this year, according to data released on 7 September.
Nature (16 September 2004)
| Full Text |
Congress may force drug firms to reveal clinical trial data
Congressional investigators have threatened to enact laws that will make the disclosure of data from clinical trials compulsory.
Nature (16 September 2004)
| Full Text |
Critics slate ethical leeway in California stem-cell proposal
Opponents of California's $3-billion plan to fund embryonic stem-cell research say that the proposal would give researchers carte blanche to rewrite well-established ethical guidelines to suit their needs.
Nature (16 September 2004)
| Full Text |
Rule change set to cost Britain Framework cash
British universities say they could be forced to drop out of the European Union's Framework research programme under rules being proposed by the UK government.
Nature (16 September 2004)
| Full Text |
Biomedical agency floats open-access plan
The main biomedical research agency in the United States has issued a plan that would make the results of all research that it supports freely available shortly after their initial publication in the scientific literature.
Nature (9 September 2004)
| Full Text |
China increases share of global scientific publications
China's scientific growth is keeping up with its meteoric economic rise, according to figures released last week. But the growth seems to vary widely between fields and the quality of the work may be lagging in some of them.
Nature (9 September 2004)
| Full Text |
Ethics review slams government panels over conflicts of interest
A US government ethics office is demanding that agencies comply more fully with rules requiring experts on advisory panels to declare potential conflicts of interest.
Nature (2 September 2004)
| Full Text |
Organizers claim success for Stockholm science jamboree
Sceptics said it couldn't work, but 1,800 people came to the EuroScience Open Forum (ESOF) meeting in Stockholm, Sweden, from 25–28 August, exceeding the 1,500 expected.
Nature (2 September 2004)
| Full Text |
Wildlife campaigners fight planned site for Scripps Florida
An environmental backlash is threatening to delay the Scripps Research Institute's plans to build a huge research and biotechnology complex near Palm Beach in Florida.
Nature (2 September 2004)
| Full Text |
Lab chiefs fear European rules will cost postdoc jobs
British researchers are expressing concern that European Union (EU) rules intended to give workers more job security could wreck the careers of postdocs in their labs.
Nature (2 September 2004)
| Full Text |
Microchip industry proposes broad survey of worker health
Makers of microchips are planning a study of more than 200,000 people to determine whether workers in semiconductor plants have an increased risk of cancer.
Nature (2 September 2004)
| Full Text |
Five-year grant gets bird database off to a flying start
Snakes, lizards and bears all have comprehensive specimen databases — and now one is being set up for the bird family.
Nature (2 September 2004)
| Full Text |
High-flying patents get their wings clipped in Europe
Researchers in Europe are benefiting from the European Patent Office's (EPO) decision to prune several high-profile patents, a result of key differences between US and European policy.
Nature Medicine (September 2004)
| Full Text |
California dreaming about 'ill-conceived' stem cell plan
Come November, California might become the first state to fund stem cell research, in direct opposition to the federal government's policy.
Nature Medicine (September 2004)
| Full Text |
Fast-track' drug approvals hit speed bumps in Japan
Families of patients who died after receiving the controversial cancer drug Iressa (gefitinib) in July filed a lawsuit against manufacturer AstraZeneca and the Japanese government for ¥33 million, alleging that the drug, approved in Japan in 2002 after only five months of review, showed neither adequate safety nor efficacy in clinical trials.
Nature Medicine (September 2004)
| Full Text |
UK cracks down on animal-rights activists
Animal-rights activists were dealt a dual blow in late July when the UK government and the pharmaceutical industry announced new legislation and funds to support animal research.
Nature Medicine (September 2004)
| Full Text |
NIH lab shutdown raises concerns about US prion research
Closing of the agency's only internal prion lab raises concerns.
Nature Medicine (September 2004)
| Full Text |
Cash-strapped biotechs find financing alternative
Publicly quoted biotech companies increasingly rely on private investors to raise money.
Nature Biotechnology (September 2004)
| Full Text |
As products enter clinic...scientists shown the door
Companies are left with fewer resources to do early stage research as their focus shifts when their products enter clinical trials.
Nature Biotechnology (September 2004)
| Full Text |
Russia becomes attractive as a source of IP for biotechs
Foreign companies in search of original intellectual property strike deals with Russian scientists, encouraged by the imminent accession of Russia to the World Trade Organization.
Nature Biotechnology (September 2004)
| Full Text |
EU to review rare disease drugs market exclusivity
Biotech companies fear that tightening of the orphan drug legislation would remove the main incentive to produce drugs for rare diseases.
Nature Biotechnology (September 2004)
| Full Text |
France to focus on a few biotech clusters
As part of its 2005 budget, France's interior minister proposes the creation of two or three biotechnology clusters to attract startups as well as mature companies.
Nature Biotechnology (September 2004)
| Full Text |
News in brief
Scripps stays wedded to original Florida site |
President of Whitehead Institute steps down |
Flesh-eating bacteria get a taste of success |
Primate lab charged with cruelty to chimpanzees |
Society admits paper was published in error |
Cloning paper pulled from publication after media circus |
US centres set up to ponder broader issues of genetics |
Singapore opens door to stem-cell research |
Neurobiologist scores a double first to take MIT presidency |
Small price to pay for drug-company lawsuit |
Alleged spy sues Japanese government |
Britain issues first therapeutic cloning license |
US to speed up cancer drug approval |
UK set to boost research spending |
Francis Crick, 88, discoverer of DNA's secrets |
New stock option reporting |
Latin America initiative |
US biotech licenses drugs from Cuba |
More proteomics in China |
RNAi drug enters trials |
First ethnic drug
News Features
Enzymes: By chance, or by design?
Enzymes are well known for speeding up reactions. But have they evolved to use quantum mechanics to exert their effects? Philip Ball meets the researchers who are trying to find out.
Nature (23 September 2004)
| Full Text |
Head to head
The party conventions are over, and the candidates have been anointed. Now it's a straight race to the tape between President George W. Bush and his challenger John Kerry. Nature asked them where they stand on science.
Nature (16 September 2004)
| Full Text |
Bitter pills
They were hailed as wonder drugs to banish depression, but may cause suicidal thoughts in some children. Companies are under attack for failing to publish these data. Erika Check considers the science behind a scandal.
Nature (9 September 2004)
| Full Text |
Coming soon: a global grid for cancer research
The US NCI is spearheading efforts to create a national network for storing cancer tissue samples as well as an international informatics grid to share data.
Nature Biotechnology (September 2004)
| Full Text |
|
